ICLR Stock Analysis: Buy, Sell, or Hold?
ICLR - Icon Plc
$180.25
-5.64 (-3.03%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026
17d
Get Alerted When ICLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ICLR shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: ICLR shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$203.05
Based on 2.6% avg growth
INTRINSIC VALUE TODAY
$126.08
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICLR is currently trading at $180.25, which is considered oversold relative to its 30-day fair value range of $179.33 to $191.70. The stock's valuation (Forward PE: 14.1) is in line with its historical norms (13.5). At these levels, the market is pricing in 1.3% annual earnings growth.
Technical Outlook: Technically, ICLR is in a uptrend. Immediate support is located at $173.41, while resistance sits at $191.00. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $206.38 (+11.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICLR is in a uptrend. Immediate support is located at $173.41, while resistance sits at $191.00. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $206.38 (+11.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$179.33 -
$191.70
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading below Wall St target ($206.38)
- BULLISH: Expecting earnings turnaround to 1.3% growth with 0.6% revenue growth
Fair Price Analysis
30-Day Fair Range
$179.33 -
$191.70
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$173.42
Resistance Level
$191.00
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
14.05
Wall Street Target
$206.38
(+11.0%)
Revenue Growth (YoY)
0.6%
Earnings Growth (YoY)
-98.7%
Profit Margin
7.4%
Valuation Premium vs History
+1.3% premium
PE vs Historical
14.1 vs 13.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.3%
(market-implied from PE analysis)
1-Year Target
$188.31
(+1%)
2-Year Target
$190.75
(+3%)
3-Year Target
$193.23
(+4%)
3-Yr Target (if PE normalizes)
(PE: 14→14)
PE COMPRESSION
$185.70
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 1.2%)
$305.75
(+65%)
Base:
(SPY PE: 14.0, Growth: 1.2%)
$192.61
(+4%)
Bear:
(PE: 11.9, Growth: 1.2%)
$163.72
(-12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 25.11 | Current EPS (TTM): $7.42
Bull Case
$365.50
(+103%)
Analyst growth 78.3%, PE expands to 27.6
Base Case
$332.27
(+84%)
Market implied 78.3%, PE stable at 25.1
Bear Case
$126.70
(-30%)
Severe decline -20.0%, PE contracts to 21.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 8:24 AM ET
Data refreshes hourly during market hours. Next update: 9:24 AM
Data refreshes hourly during market hours. Next update: 9:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced ICLR Option Strategies
Professional options setups generated by AI based on today's ICLR price and gamma walls.
